Jointown Pharmaceutical Group Co Ltd
SSE:600998

Watchlist Manager
Jointown Pharmaceutical Group Co Ltd Logo
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Watchlist
Price: 5.53 CNY -2.12% Market Closed
Market Cap: 27.9B CNY
Have any thoughts about
Jointown Pharmaceutical Group Co Ltd?
Write Note

Jointown Pharmaceutical Group Co Ltd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jointown Pharmaceutical Group Co Ltd
Deferred Income Tax Peer Comparison

Comparables:
1099
601607
C
600511
000963
Q
301015

Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Deferred Income Tax
ÂĄ370.8m
CAGR 3-Years
-20%
CAGR 5-Years
64%
CAGR 10-Years
31%
Sinopharm Group Co Ltd
HKEX:1099
Deferred Income Tax
ÂĄ877.8m
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
4%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Deferred Income Tax
ÂĄ1B
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
10%
C
China National Medicines Corp Ltd
SSE:600511
Deferred Income Tax
ÂĄ27.5m
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
25%
Huadong Medicine Co Ltd
SZSE:000963
Deferred Income Tax
ÂĄ173.4m
CAGR 3-Years
28%
CAGR 5-Years
57%
CAGR 10-Years
N/A
Q
Qingdao Baheal Medical Inc
SZSE:301015
Deferred Income Tax
ÂĄ29m
CAGR 3-Years
80%
CAGR 5-Years
44%
CAGR 10-Years
N/A

See Also

What is Jointown Pharmaceutical Group Co Ltd's Deferred Income Tax?
Deferred Income Tax
370.8m CNY

Based on the financial report for Jun 30, 2024, Jointown Pharmaceutical Group Co Ltd's Deferred Income Tax amounts to 370.8m CNY.

What is Jointown Pharmaceutical Group Co Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
31%

Over the last year, the Deferred Income Tax growth was -20%. The average annual Deferred Income Tax growth rates for Jointown Pharmaceutical Group Co Ltd have been -20% over the past three years , 64% over the past five years , and 31% over the past ten years .

Back to Top